The prevalence of the types of hepatitis C virus in Spanish blood donors: Results of a national multicenter study;Prevalencia de tipos del virus de la hepatitis C en donantes de sangre españoles: Resultados de un estudio multicéntrico de ámbito estatal

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 17, Issue 9, 1999, Pages 448-453

  León, Pilar ^a   López, José A ^b   Amela, Carmen ^c   Elola, Consuelo ^b   Echevarría, José M ^b  

^a Serv de Microbiol Diagnostica   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c CARLOS III INSTITUTE OF HEALTH   (Spain)

Author keywords

Blood donors; Genotyoes; Hepatitis C virus; Molecular epidemiology; Serotypes

Indexed keywords

HEPATITIS C ANTIBODY;

ARTICLE; BLOOD; BLOOD DONOR; CLASSIFICATION; CLINICAL TRIAL; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MULTICENTER STUDY; PREVALENCE; RISK FACTOR; SPAIN;

BLOOD DONORS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; PREVALENCE; RISK FACTORS; SPAIN;

EID: 0033218496     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region. J Gen Virol 1993; 74: 2.391-2.399.
2. Tokita H, Okamoto H, Tsuda F, Song P, Nakata S, Chosa T et al. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eight and ninth major genetic groups. Proc Natl Acad Sci USA 1994; 91: 11.022-11.026.
3. Tokita H, Okamoto H, Iizuka H, Kishimoto J, Tsuda F, Lesmana LA et al. Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol 1996; 77: 293-301.
4. Simmonds P, Mellor J, Sakuldamrongpanich T, Nuchaprayoon C, Tanprasert S, Holmes EC et al. Evolutionary analysis of variants of hepatitis C found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol 1996; 77: 3.013-3.024.
5. Silini E, Bono F, Cividini A, Cerino S, Bruno S, Rossi G et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 1995; 21: 285-290,
6. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S et al. Factors predictive of response to interferon alpha therapy in hepatitis C virus infection. Hepatology 1994; 19: 1.088-1.094.
7. Widell A, Elmud H, Persson MH, Jonsson M. Transmision of hepatitis C virus via both erytrocyte and platelet transfusions from a single donor in serological window-phase of hepatitis C. Vox Sang 1996; 71: 55-57.
8. Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Simmonds P. Molecular epidemiology of an outbreak of infection by hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995; 345: 1.211-1.213.
9. Echevarría JM, León P, Domingo CJ, López JA, Elola C, Madurga M et al. Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain. Transfusion 1996; 36: 725-730.
10. Esteban JI, Gómez J, Martell M, Cabot B, Quer J, Camps J et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996; 334: 555-560.
11. Domínguez A, Vidal J, Bruguera M, Salleras L. Epidemiología de las hepatitis virales. Enferm Infecc Microbiol Clin 1995; 13 (Supl 1): 50-61.
12. Comunidad de Madrid. II Encuesta de serovigilancia de la Comunidad de Madrid. Documentos Técnicos en Salud Pública, n.o 29. Madrid: Consejería de Sanidad y Servicios Sociales, 1995.
13. Sánchez-Quijano A, Abad MA, Torronteras R, Rey C, Pineda JA, Leal M et al. Unexpected high prevalence of hepatitis C genotype 4 in Southern Spain. J Hepatol 1997; 27: 20-29.
14. Ravaggi A, Rossini A, Mazza C, Puoti M, Marin HG, Cariani E. Hepatitis C virus genotypes in Northern Italy: clinical and virological features. J Clin Microbiol 1996; 34: 2.822-2.825.
15. Bansell JC, Esteban R. Hepatitis C. Enferm Infecc Microbiol Clin 1995; 13 (Supl 1): 31-39.
16. Montesano L, Gutiérrez M, Bravo R, Baquero M, Soriano V. Correlation between serological and genetic methods for typing hepatitis C virus. Vox Sang 1996; 71: 190-191.
17. Forns X, Maluenda MD, López Labrador FX, Ampurdanés S, Olmedo E, Costa J et al. Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. J Clin Microbiol 1996; 34: 2.516-2.521.
18. Domingo MJ, Fernández I, Lumbreras C, Manzanares J, Morales JM, Noriega AR et al. Utilización de la hibridación de secuencias de DNA con sondas específicas de oligonucleótidos para identificar genotipos del virus de la hepatitis C. Enferm Infecc Microbiol Clin 1996; 14: 433-436.
19. Soriano V, Bravo R, García Samaniego J, Castro A, Carballo E, González-Anglada I et al. Circulating hepatitis C virus genotypes in Spain. Vox Sang 1998; 70: 180-181.
20. Bravo R, Soriano V, García Samaniego J, González J, Castro A, Colmenero M et al. Hepatitis C virus genotypes in different risk populations in Spain. J Infect Dis 1996; 183: 509-510.
21. Alonso P, Orduña A, San Miguel A, Gutiérrez MP, Lorenzo B, Eiros JM et al. Variantes del virus de la hepatitis C en diferentes grupos de riesgo. Estudio comparativo de un método de genotipificación y otro de serotipificación. Enferm Infecc Microbiol Clin 1998; 16: 111-117.
22. Pena MJ, Mosquera MM, Pérez MC, Rodríguez San Román JL, Martín JM, Avalos O et al. Prevalencia de genotipos del virus de la hepatitis C: epidemiología y características histológicas. Enferm Infecc Microbiol Clin 1998; 16: 456-460.
23. León P, López JA, Domingo CJ, Elola C, Echevarría JM and the Spanish Study Group for Blood Donors at Risk of Transmission of HCV. Serological studies and hepatitis C virus RNA in serum samples from blood donors with indeterminate results in second generation recombinant immunoblot assay (RIBA-2). Vox Sang 1994; 66: 245-246.
24. León P, López JA, Elola C, Domingo CJ, Echevarría JM. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. Vox Sang 1996; 70: 213-216.
25. León P, López JA, Elola C, Lee SR, Calmann M, Echevarría JM. Use of overlapping synthetic peptides to characterise samples from blood donors with indeterminate results to hepatitis C virus core antigen. Vox Sang 1998; 75: 32-36.
26. Stuyver L, Wyseur A, Van Arnhem W, Hernández F, Maertens G. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 1996; 34: 2.259-2.266.
27. Bhattacherjee V, Prescott L, Pike I, Rodgers B, Bell H, El-Zayadi AR et al. Use of NS4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol 1995; 76: 1.737-1.748.
28. Echevarría JE, León P, López JA, Tenorio A, Domingo CJ, Echevarría JM. HBsAg subtype distribution among different populations of HBsAg carriers in Spain. Eur J Epidemiol 1995; 11: 39-45.
29. León P, López JA, Elola C, Quan S, Echevarría JM. Typing of hepatitis C virus antibody with specific synthetic peptides in seropositive blood donors and comparison with genotyping of viral RNA. Vox Sang 1997; 72: 71-75.